Patents by Inventor Reynald LESCARBEAU

Reynald LESCARBEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002843
    Abstract: The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies.
    Type: Application
    Filed: October 13, 2022
    Publication date: January 4, 2024
    Applicants: Novartis AG, Intellia Therapeutics, Inc.
    Inventors: Anthony Edward BOITANO, Michael COOKE, Lloyd B. KLICKSTEIN, Reynald LESCARBEAU, Craig Stephen MICKANIN, Kabungo MULUMBA, Seshidhar Reddy POLICE, Jennifer SNEAD, Susan C. STEVENSON, Morag STEWART, Yi YANG
  • Publication number: 20190010495
    Abstract: The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies.
    Type: Application
    Filed: December 26, 2016
    Publication date: January 10, 2019
    Applicants: NOVARTIS AG, INTELLIA THERAPEUTICS, INC.
    Inventors: Anthony Edward BOITANO, Michael COOKE, Lloyd B. KLICKSTEIN, Reynald LESCARBEAU, Craig Stephen MICKANIN, Kabungo MULUMBA, Seshidhar Reddy POLICE, Jennifer SNEAD, Susan C. STEVENSON, Morag STEWART, Yi YANG
  • Publication number: 20180362975
    Abstract: The present invention is directed to genome editing systems, reagents and methods for immunooncology.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 20, 2018
    Inventors: Ming-Wei CHEN, Melissa DECK, Glenn DRANOFF, Craig Stephen MACKANIN, Reynald LESCARBEAU, Celeste RICHARDSON, Morag Helen STEWART, Yi YANG